• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Institute for Clinical Evaluative Sciences (ICES) Ontario Burden of Infectious Disease Study (ONBOIDS)
2010     Institute for Clinical Evaluative Sciences (ICES) Aging in Ontario: an ICES chartbook of health service use by older adults
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel versus other antiplatelet agents for secondary prevention of vascular events in adults with acute coronary syndrome or peripheral vascular disease: clinical and cost-effectiveness analyses
2010     Institute for Clinical Evaluative Sciences (ICES) How many Canadians will be diagnosed with diabetes between 2007 and 2017? Assessing population risk
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-emergency telecardiology consultation services: rapid review of clinical and cost outcomes
2010     Institute for Clinical Evaluative Sciences (ICES) Ontario Stroke Evaluation Report 2010: Technical Report.
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Teledermatology services: rapid review of diagnostic, clinical management, and economic outcomes
2010     Institute for Clinical Evaluative Sciences (ICES) Development of a consensus on evidence-based quality of care indicators for Canadian emergency departments
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Draft report: robot-assisted surgery versus open surgery and laparoscopic surgery: clinical and cost- effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Policy guidance on hip protectors in long-term care
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Argon beam coagulation in orthopaedic, urological and thoracic surgery at the MUHC: a brief report
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Biologic response modifier agents for adults with rheumatoid arthritis
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) (Update of Report 19)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Single photon emission computed tomography for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stress echocardiography for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stress echocardiography with contrast for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) 64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease
2010     Medical Advisory Secretariat (MAS) Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures
2010     Medical Advisory Secretariat (MAS) Negative pressure wound therapy: an evidence update
2010     Medical Advisory Secretariat (MAS) Epidermal Growth Factor Receptor Mutation (EGFR) testing for prediction of response to EGFR-targeting Tyrosine Kinase Inhibitor (TKI) drugs in patients with advanced non-small-cell lung cancer : an evidence-based and economic analysis
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010     Medical Advisory Secretariat (MAS) Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography for cardiovascular disease: a review of the clinical effectiveness
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography (PET) in oncology: a systematic review of clinical effectiveness and indications for use
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Second-line therapy for patients with diabetes inadequately controlled on metformin: a systematic review and cost-effectiveness analysis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review
2010     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Chronic fatigue syndrome: state of the evidence and assessment of intervention modalities in Quebec]
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of a gentamicin-loaded collagen sponge as an adjuvant antibiotic prophylaxis for colorectal surgery
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure.
2010     Technology Assessment Unit of the McGill University Health Centre (MUHC) Negative Pressure Wound Therapy (NPWT) Update to Report 19
2010     Medical Advisory Secretariat (MAS) Endovascular Repair of Abdominal Aortic Aneurysms in Low Surgical Risk Patients: rapid review
2010     Medical Advisory Secretariat (MAS) Population-based strategies for smoking cessation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pulmonary rehabilitation for chronic obstructive pulmonary disease
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Polymerase chain reaction tests for methicillin-resistant staphylococcus aureus in hospitalized patients: clinical and cost-effectiveness analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgery for severe obesity: systematic review and economic evaluation
2010     Medical Advisory Secretariat (MAS) Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic-based strategies for smoking cessation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management
2010     Medical Advisory Secretariat (MAS) Positron emission tomography (PET) for the assessment of myocardial viability
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Epidermal growth factor receptor mutation analysis in advanced non-small cell lung cancer: review of economic evaluations and framework for economic analyses
2010     Medical Advisory Secretariat (MAS) Primary angioplasty and thrombolysis for the treatment of acute ST-segment elevated myocardial infarction : an evidence update
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for difficult wound healing: systematic review of clinical effectiveness and cost-effectiveness
2010     Medical Advisory Secretariat (MAS) Magnetic resonance imaging (MRI) for the assessment of myocardial viability
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Self-directed cognitive behavioural therapy for adults with diagnosis of depression: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral disease of the lower extremities
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the management of neuropathic pain: review of clinical effectiveness
2010     Medical Advisory Secretariat (MAS) Endovascular repair of abdominal aortic aneurysms in low surgical risk patients
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of diuretics for hypertension in patients with reduced renal function: a review of clinical effectiveness, safety, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Telepathology: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Clopidogrel versus other antiplatelet agents in the secondary prevention of vascular events in adults with cerebrovascular disease: clinical and cost-effectiveness analyses
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Initial staging of oesophageal cancer: systematic review of the performance of diagnostic methods]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Erythropoiesis-stimulating agents for anemia of cancer or of chemotherapy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Technologies to reduce errors in dispensing and administration of medication in hospitals: clinical and economic analyses
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Opportunity costs associated with technology expansion in the MUHC
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The Impella percutaneous ventricular assist device
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [In vitro fertilization: comparative profile of European and Oceania countries]
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Clinical efficacy and cost of Allogenic Acellular Dermal Matrix (AADM) in implant-based breast reconstruction of post mastectomy cancer patients
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy and cost-effectiveness of Collatamp-G for infection prophylaxis in cardiac surgery
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea: an update
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for treatment of Barrett's esophagus: A systematic review and cost analysis
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Sentinel lymph node biopsy in breast cancer management: technical aspects]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation
2009     Technology Assessment at SickKids (TASK) Systematic review on orchidopexy for the Canadian Paediatric Surgical Wait Times project
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pyxis and medDISPENSE automated medication dispensing systems: a review of the clinical benefits and harms, cost-effectiveness, and guidelines for use
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oxybutynin, tolterodine, and darifenacin: review of cognitive adverse events
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared to fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: supplementary analyses relating to risk of infection from an unknown virus
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) n-3 lipids for patients on total parenteral nutrition: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography for pediatric patients: review of clinical effectiveness and indications for use
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins: review of the comparative effectiveness for various indications
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Specialty mattresses for the prevention and management of pressure ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines